It doesn’t get much trendier these days than either 3-dimentional (3D) or stem cells. Put the two together and you have cooler-than-cool 3D stem cell models, a topic pregnant with possibilities.
The Biotechnology Industry Organization (BIO) met in San Diego last week bringing together academic and industry leaders. The goal of the meeting - to foster collaboration, promote innovation, bring cures to the clinic, and encourage economic growth. Some pretty intense objectives! How can such idealized goals be reached? There was a palpable energy around the answer: Partnering.
In Part I of this series we introduced T cell based immunotherapy and in Part II we discussed how chimeric antigen receptors (CARs) expressing T cells can be even more potent. In Part III below, we expand this concept further by covering hematopoetic stem cells and additional ways they can be engineered for promising immunotherapy of cancer and leukemia.